ABVC BioPharma, Inc. Federal Deposit Insurance Corporation Premium Expense
ABVC BioPharma, Inc. (ABVC) reported Federal Deposit Insurance Corporation Premium Expense of $250.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:FederalDepositInsuranceCorporationPremiumExpense · last filed 2026-08-12
- ABVC BioPharma, Inc. federal deposit insurance corporation premium expense for the quarter ending 2026-06-30 was $0.00.
- ABVC BioPharma, Inc. federal deposit insurance corporation premium expense for the quarter ending 2026-03-31 was $250.00K.
- ABVC BioPharma, Inc. federal deposit insurance corporation premium expense for the quarter ending 2025-12-31 was $0.00.
- ABVC BioPharma, Inc. federal deposit insurance corporation premium expense for the quarter ending 2025-09-30 was $0.00.
- ABVC BioPharma, Inc. federal deposit insurance corporation premium expense for fiscal 2025 was $250.00K.
| Period end | Federal Deposit Insurance Corporation Premium Expense 3 month | Federal Deposit Insurance Corporation Premium Expense 6 month | Federal Deposit Insurance Corporation Premium Expense 9 month | Federal Deposit Insurance Corporation Premium Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $250.00K 10-Q · filed 2026-08-12 | $250.00K derived: sum of 3 quarters · filed 2026-08-12 | $250.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-03-31 | $250.00K 10-Q · filed 2026-05-18 | $250.00K derived: sum of 2 quarters · filed 2026-05-18 | $250.00K derived: sum of 3 quarters · filed 2026-05-18 | |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q/A 9 month · filed 2026-03-03 | $0.00 derived: sum of 2 quarters · filed 2026-03-03 | $250.00K 10-K · filed 2026-03-03 | |
| 2025-09-30 | $0.00 derived: 10-Q/A 9 month − 10-Q 6 month · filed 2026-03-03 | $250.00K 10-Q/A · filed 2026-03-03 | ||
| 2025-06-30 | $250.00K 10-Q · filed 2025-08-13 |